Page last updated: 2024-10-30

lobenzarit and Psoriasis

lobenzarit has been researched along with Psoriasis in 1 studies

lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takematsu, H1
Ohkochi, K1
Terui, T1
Tagami, H1

Other Studies

1 other study available for lobenzarit and Psoriasis

ArticleYear
Psoriatic lesions do not respond to oral administration of lobenzarit disodium, an inhibitor of interleukin 1 production.
    Dermatologica, 1989, Volume: 179, Issue:2

    Topics: Adolescent; Adult; Animals; Child; Depression, Chemical; Drug Evaluation; Female; Humans; Interleuki

1989